These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2451137)

  • 1. Behavioural effects of intrathecally injected tachykinins in rats with peripheral nerve transection.
    Kuwahara H; Sakurada T; Sakurada S; Yonezawa A; Ando R; Kisara K; Osakada F; Munekata E
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Dec; 336(6):656-60. PubMed ID: 2451137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of substance P, neurokinin A, physalaemin and eledoisin in facilitating a nociceptive reflex in the rat.
    Cridland RA; Henry JL
    Brain Res; 1986 Aug; 381(1):93-9. PubMed ID: 2428434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of tachykinins with an adrenergic receptor in the rat urinary bladder.
    Mathison R; Solomos D
    Eur J Pharmacol; 1985 Mar; 109(3):327-33. PubMed ID: 2580719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioural effects of tachykinins and related peptides.
    Elliott PJ; Iversen SD
    Brain Res; 1986 Aug; 381(1):68-76. PubMed ID: 2428433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tachykinin-like central activity of neuromedin K in mice.
    Vaught JL; Post LJ; Jacoby HI; Wright D
    Eur J Pharmacol; 1984 Aug; 103(3-4):355-7. PubMed ID: 6208040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoreceptor responses to substance P, physalaemin and eledoisin: evidence for neurokinin-1 receptors in the cat carotid body.
    Prabhakar NR; Kou YuR ; Runold M
    Neurosci Lett; 1990 Dec; 120(2):183-6. PubMed ID: 1705679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substance P analogues containing D-histidine antagonize the behavioural effects of intrathecally co-administered substance P in mice.
    Sakurada T; Yamada T; Sakurada S; Kisara K; Ohba M
    Eur J Pharmacol; 1989 Dec; 174(2-3):153-60. PubMed ID: 2483548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NK-1 receptor mediation of neurogenic plasma extravasation in rat skin.
    Andrews PV; Helme RD; Thomas KL
    Br J Pharmacol; 1989 Aug; 97(4):1232-8. PubMed ID: 2477105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of cardiovascular and bronchoconstrictor effects of substance P, substance K and other tachykinins.
    Hua X; Lundberg JM; Theodorsson-Norheim E; Brodin E
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Dec; 328(2):196-201. PubMed ID: 6084817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminal substance P fragments inhibit the spinally induced, NK 1 receptor mediated behavioural responses in mice.
    Sakurada T; Tan-No K; Yamada T; Sakurada S; Kisara K; Ohba M; Terenius L
    Life Sci; 1990; 47(20):PL109-13. PubMed ID: 1701844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A selective and extremely potent antagonist of the neurokinin-1 receptor.
    Sakurada T; Manome Y; Tan-No K; Sakurada S; Kisara K; Ohba M; Terenius L
    Brain Res; 1992 Oct; 593(2):319-22. PubMed ID: 1280526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperalgesia produced by intrathecal substance P and related peptides: desensitization and cross desensitization.
    Moochhala SM; Sawynok J
    Br J Pharmacol; 1984 Jun; 82(2):381-8. PubMed ID: 6203593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the responses to the sensory neuropeptides, substance P, neurokinin A, neurokinin B and calcitonin gene-related peptide and to trigeminal nerve stimulation in the iris sphincter muscle of the rabbit.
    Muramatsu I; Nakanishi S; Fujiwara M
    Jpn J Pharmacol; 1987 May; 44(1):85-92. PubMed ID: 2442444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping of brain sites sensitive to the antidipsogenic effect of tachykinins.
    Massi M; de Caro G; Perfumi M; Venturi F
    Peptides; 1988; 9(2):347-56. PubMed ID: 2453857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tachykinin receptors in smooth muscles: a study with agonists (substance P, neurokinin A) and antagonists.
    Mizrahi J; Dion S; D'Orléans-Juste P; Escher E; Drapeau G; Regoli D
    Eur J Pharmacol; 1985 Nov; 118(1-2):25-36. PubMed ID: 2417867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of substance P and neurokinin A (substance K) on motor behavior: unique effect of substance P attributable to its amino-terminal sequence.
    Hall ME; Grantham P; Limoli J; Stewart JM
    Brain Res; 1987 Sep; 420(1):82-94. PubMed ID: 2445433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphoramidon potentiates mammalian tachykinin-induced biting, licking and scratching behaviour in mice.
    Sakurada T; Tan-No K; Yamada T; Sakurada S; Kisara K
    Pharmacol Biochem Behav; 1990 Dec; 37(4):779-83. PubMed ID: 1709505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Action of the newly discovered mammalian tachykinins, substance K and neuromedin K, on gastroduodenal motility of anesthetized dogs.
    Kuwahara A; Yanaihara N
    Regul Pept; 1987 Apr; 17(4):221-8. PubMed ID: 2438728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioural and antinociceptive effects of intrathecally injected substance P analogues in mice.
    Post C; Folkers K
    Eur J Pharmacol; 1985 Jul; 113(3):335-43. PubMed ID: 2412846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further evidence for multiple tachykinin receptors.
    Growcott JW; Jamieson A; Tarpey AV; Topham LD
    Eur J Pharmacol; 1982 Dec; 86(1):59-64. PubMed ID: 6186499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.